- Vienna '18
- Athens 2019
- ESCRS Player
- On Demand
- ESCRS iLearn
- ESCRS YO's
First Author: H.El Sobky EGYPT
Co Author(s): A. Sarhan
Back to previous
to evaluate effects and safety of primary phacoemulsification and intraocular lens implantation in patients with controlled chronic angle closure glaucoma (CACG) or primary angle closure (PAC) with or without cataract.
Ophthalmology Development, Menoufia University Hospital, Shibin El kom, Egypt.
phacoemulsification plus intraocular lens implantation were done in 32 eyes of 32 patients, 8 patient had coexisting mild cataract and 24 patients presented with clear lens. Intra ocular pressure (IOP), visual acuity, anterior champer depth (ACD), number of antiglaucoma medication were evaluated.
The post operative IOP was reduced in all eyes (100%). Preoperative IOP was 46.76+ 14.62 mm Hg, which decreased postoperatively to 17.55+9.54 mm Hg at 1 day, 11.65+2.65 mm Hg at 1 month and 10.60+2.23 mm Hg at 3months (p<0.001). The number of antiglaucoma medication decreased from 3.76+1.11 to 0.13+0.32 (p<0.001). Preoperative ACD was 2.04+ 0.31 which increased to 3.54 +0.32 mm postoperatively (p<0.001). Visual acuity improved from 1.12+ 0.67 to 0.74+0.53 (p<0.001). unE may, vao day coi co con nho nay ngon lam http://nhatquanglan.xlphp.net/ E may, vao day coi co con nho nay ngon lam http://nhatquanglan.xlphp.net/ FC:WINDOWShinhem.scro
primary phacoemulsification plus intraocular lens implantation seems to be a safe and effective method in lowering IOP, reducing the use of antiglaucoma medications and improving vision and can be considered a first treatment of choice in patients with controlled CACG or PAC.